-
Artur V Cideciyan
Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
-
Samuel G Jacobson
Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
-
Arlene V Drack
Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States
-
Allen C Ho
Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, United States
-
Alexandra Garafalo
Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
-
Alejandro J Roman
Dept of Ophthalmology, Scheie Eye Institute, Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
-
Mike Schwartz
ProQR Therapeutics, Netherlands
-
Patricia Biasutto
ProQR Therapeutics, Netherlands
-
Wilma de Wit
ProQR Therapeutics, Netherlands
-
Michael E Cheetham
UCL Institute of Ophthalmology, London, United Kingdom
-
Peter S Adamson
ProQR Therapeutics, Netherlands
UCL Institute of Ophthalmology, London, United Kingdom
-
David Rodman
ProQR Therapeutics, Netherlands
-
Julie De Zaeytijd
Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium
-
Caroline Van Cauwenbergh
Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium
-
Bart P Leroy
Department of Ophthalmology, Ghent University and Ghent University Hospital, Ghent, Belgium
Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium
-
Stephen R Russell
Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States